These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


443 related items for PubMed ID: 16449073

  • 1. Growth in pre-pubertal children with myelomeningocele (MMC) on growth hormone (GH): the KIGS experience.
    Trollmann R, Bakker B, Lundberg M, Doerr HG.
    Pediatr Rehabil; 2006; 9(2):144-8. PubMed ID: 16449073
    [Abstract] [Full Text] [Related]

  • 2. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
    Craig ME, Cowell CT, Larsson P, Zipf WB, Reiter EO, Albertsson Wikland K, Ranke MB, Price DA, KIGS International Board.
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
    [Abstract] [Full Text] [Related]

  • 3. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO, KIGS International Board.
    Horm Res; 2007 Aug; 68(2):53-62. PubMed ID: 17228181
    [Abstract] [Full Text] [Related]

  • 4. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F, Ranke MB, Bakker B, Lindberg A, Cowell CT, Albertsson-Wikland K, Reiter EO, Price DA.
    Horm Res; 2005 Aug; 63(1):40-7. PubMed ID: 15627781
    [Abstract] [Full Text] [Related]

  • 5. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with human growth hormone. Analysis of the Kabi Pharmacia International Growth Study.
    Ranke MB, Guilbaud O.
    Acta Paediatr Scand Suppl; 1991 Aug; 379():109-15; discussion 116. PubMed ID: 1815451
    [Abstract] [Full Text] [Related]

  • 6. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
    Cavallo L, Gurrado R, Zecchino C, Manolo F, De Sanctis V, Cisternino M, Caruso-Nicoletti M, Galati M.
    J Pediatr Endocrinol Metab; 1998 Aug; 11 Suppl 3():845-9. PubMed ID: 10091155
    [Abstract] [Full Text] [Related]

  • 7. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth?
    Seminara S, Stagi S, Candura L, Scrivano M, Lenzi L, Nanni L, Pagliai F, Chiarelli F.
    Horm Metab Res; 2005 Dec; 37(12):751-6. PubMed ID: 16372229
    [Abstract] [Full Text] [Related]

  • 8. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K, Xhrouet-Heinrichs D, Massa G, Vandeweghe M, Bourguignon JP, De Schepper J, de Zegher F, Ernould C, Heinrichs C, Malvaux P, Craen M.
    J Pediatr Endocrinol Metab; 2001 Dec; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [Abstract] [Full Text] [Related]

  • 9. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D, Garel C, Limoni C, Czernichow P, Léger J.
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [Abstract] [Full Text] [Related]

  • 10. Earlier initiation of GH therapy does not influence adult height but enables earlier start of pubertal induction in children with multiple pituitary hormone deficiency.
    Kawai M, Momoi T, Mamada M, Yorifuji T, Nakahata T.
    Clin Endocrinol (Oxf); 2004 May; 60(5):608-12. PubMed ID: 15104564
    [Abstract] [Full Text] [Related]

  • 11. Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone.
    Westphal O, Lindberg A, Swedish KIGS National Board.
    Acta Paediatr; 2008 Dec; 97(12):1698-706. PubMed ID: 18976357
    [Abstract] [Full Text] [Related]

  • 12. Final height in children with medulloblastoma treated with growth hormone.
    Ranke MB, Price DA, Lindberg A, Wilton P, Darendeliler F, Reiter EO.
    Horm Res; 2005 Dec; 64(1):28-34. PubMed ID: 16103682
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
    Lindgren AC, Lindberg A.
    Horm Res; 2008 Dec; 70(3):182-7. PubMed ID: 18663319
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS, Lundgren F.
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect.
    Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, Gill A, Chaussain JL, Frisch H, Yturriaga R, Attanasio AF.
    J Pediatr; 2005 Jan; 146(1):45-53. PubMed ID: 15644821
    [Abstract] [Full Text] [Related]

  • 16. Growth pattern and skeletal maturation following growth hormone therapy in growth hormone deficiency: factors influencing outcome.
    Bajpai A, Kabra M, Gupta AK, Menon PS.
    Indian Pediatr; 2006 Jul; 43(7):593-9. PubMed ID: 16891678
    [Abstract] [Full Text] [Related]

  • 17. Catch-up growth in autosomal dominant isolated growth hormone deficiency (IGHD type II).
    Binder G, Iliev DI, Mullis PE, Ranke MB.
    Growth Horm IGF Res; 2007 Jun; 17(3):242-8. PubMed ID: 17360215
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic stem cell transplantation during childhood.
    Bakker B, Oostdijk W, Geskus RB, Stokvis-Brantsma WH, Vossen JM, Wit JM.
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):589-97. PubMed ID: 17590170
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency.
    Giovenale D, Meazza C, Cardinale GM, Farinelli E, Mastrangelo C, Messini B, Citro G, Del Vecchio M, Di Maio S, Possenti I, Bozzola M.
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):433-7. PubMed ID: 18030209
    [Abstract] [Full Text] [Related]

  • 20. Short Children with CHARGE Syndrome: Do They Benefit from Growth Hormone Therapy?
    Dörr HG, Boguszewski M, Dahlgren J, Dunger D, Geffner ME, Hokken-Koelega AC, Lindberg A, Polak M, Rooman R, KIGS International Board.
    Horm Res Paediatr; 2015 Oct; 84(1):49-53. PubMed ID: 26044035
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.